ERA4Health to Launch NANOTECMEC Call
Upcoming call for nanomedicine projects to foster innovation for new medical applications.
The EU-funded ERA4Health Partnership has pre-announced an upcoming call on Nano and Advanced Technologies for Disease Prevention, Diagnostic and Therapy (NANOTECMEC).
The aims of the NANOTECMEC call are to:
- Support translational research projects that combine innovative approaches in the field of nanomedicine.
- Encourage and enable transnational collaboration between academic research (public and private partners ie, research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital, healthcare settings and other healthcare organisations) or R&D activities from industrial enterprises of all sizes.
The participation of medical doctors and clinicians is strongly encouraged. SMEs (small and medium-size enterprises) are also strongly encouraged to part.
Project proposals will address multidisciplinary and translational research. Applications must cover at least one of the following nanomedicine areas:
- Regenerative medicine.
Only transnational projects will be funded and consortia must be composed of a minimum of three eligible and a maximum of five eligible partners from at least three different countries participating in the call: Belgium; Estonia; France; Hungary; Israel; Italy; Latvia; Lithuania; Norway; Poland; Portugal; Romania; Slovakia; Spain; Taiwan; The Netherlands; and Türkiye.
Project partners will be funded by their relevant national/regional funding organisation. Eligible costs and funding rules will vary between the respective funding organisations.
The NANOTECMEC call is scheduled to be published on 14 November 2023. A webinar infoday will be held on 21 November 2023 to mark the opening of the submission system for pre-proposals.
The pre-proposal submission deadline will be 30 January 2024 (16:00).
(This report was the subject of a RESEARCHconnect Newsflash.)